The Court of Appeal allowed ZyXEL’s appeal, finding that in light of its waiver of its RAND licence rights, declaratory relief to determine the scope and terms of the licence which TQD was bound to offer to the two ZyXEL parties would no longer serve a useful purpose.
Case date: 18 July 2019
Case number: [2019] EWCA Civ 1277
Court: Court of Appeal of England and Wales, Civil Division
A full summary of this case has been published on Kluwer IP Law.
________________________
To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.
